Borderline ovarian tumors: key points and workshop summary.
This article documents major points of agreement and disagreement among experts invited to participate in a Borderline Ovarian Tumor Workshop held in Bethesda, MD, on August 27-28, 2003. It is suggested that controversies related to the diagnosis and management of these tumors are often related to lack of data in the literature (small numbers of cases, unreported or unclear criteria for diagnosis and follow-up, insufficient length of follow-up, etc), and specific recommendations are made for further investigation and for reporting of data in future studies.
Silverberg
Steven G
SG
Department of Pathology, University of Maryland School of Medicine, Baltimore 21201, USA.
Bell
Debra A
DA
Kurman
Robert J
RJ
Seidman
Jeffrey D
JD
Prat
Jaime
J
Ronnett
Brigitte M
BM
Copeland
Larry
L
Silva
Elvio
E
Gorstein
Fred
F
Young
Robert H
RH
D005260:Female; D006801:Humans; D008396:Maryland; D009316:National Institutes of Health (U.S.); D010051:Ovarian Neoplasms / Q000473:pathology*; D010336:Pathology / Q000193:education* / Q000379:methods; D014481:United States